|
|||||
|
|
Direct‐acting antivirals in hepatitis C virus (HCV)‐infected and HCV/HIV‐coinfected patients: real‐life safety and efficacy |
|
| Abstract: | |
| Keywords: | direct‐acting antivirals hepatitis C virus kinetics hepatitis C virus polymorphisms hepatitis C virus/HIV coinfection |